Scholarlink

Background <p>Congenital pulmonary airway malformation (CPAM) belongs to rare lung abnormalities which may result in poor lung development outcomes. However, the etiology of CPAM has not been well described.</p> Methods <p>In this study, whole-exome sequencing (WES) technology was used to sequence 9 CPAM families to screen the pathogenic genes and their mutations for CPAM. Sanger sequencing was performed for verify the functions of these mutations.</p> Results <p>We found compound heterozygous mutations in <i>OBSCN</i> gene in two patients with CPAM: one with p.G8837A mutation inherited from her father and p.G1126S mutation inherited from her mother; the other with p.R5167W mutation inherited from his father and p.A7475T mutation inherited from his mother. Immunofluorescence results showed that the expression of OBSCN protein in the central lung tissue of CPAM patients was lower than that in the distal lung tissue of the lesion, and the expression of OBSCN protein was decreased in <i>OBSCN</i> mutated. We further explored the expression of <i>OBSCN</i> during mouse lung development, confirming that the gene mainly acts on the pseudoglandular stage.</p> Conclusions <p>The <i>OBSCN</i> gene may play a key role in pseudoglandular stage during mouse lung development. The mutation of <i>OBSCN</i> gene may play a role in promoting the occurrence of CPAM, providing a possible therapeutic target for clinical intervention of CPAM.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Novel compound heterozygous OBSCN variants in Chinese children with congenital pulmonary airway malformation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年3月28日

查看全文
  • Jiali Xu,
  • Siyu Ma,
  • Zhaocong Yang,
  • Yang Xu,
  • Jirong Qi,
  • Min Da,
  • Xuming Mo

摘要

Background

Congenital pulmonary airway malformation (CPAM) belongs to rare lung abnormalities which may result in poor lung development outcomes. However, the etiology of CPAM has not been well described.

Methods

In this study, whole-exome sequencing (WES) technology was used to sequence 9 CPAM families to screen the pathogenic genes and their mutations for CPAM. Sanger sequencing was performed for verify the functions of these mutations.

Results

We found compound heterozygous mutations in OBSCN gene in two patients with CPAM: one with p.G8837A mutation inherited from her father and p.G1126S mutation inherited from her mother; the other with p.R5167W mutation inherited from his father and p.A7475T mutation inherited from his mother. Immunofluorescence results showed that the expression of OBSCN protein in the central lung tissue of CPAM patients was lower than that in the distal lung tissue of the lesion, and the expression of OBSCN protein was decreased in OBSCN mutated. We further explored the expression of OBSCN during mouse lung development, confirming that the gene mainly acts on the pseudoglandular stage.

Conclusions

The OBSCN gene may play a key role in pseudoglandular stage during mouse lung development. The mutation of OBSCN gene may play a role in promoting the occurrence of CPAM, providing a possible therapeutic target for clinical intervention of CPAM.